http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100393133-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B55-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B53-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B55-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-60 |
| filingDate | 1995-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100393133-B1 |
| titleOfInvention | Methods of racemization and asymmetry conversion used in the manufacture of levobupivacaine and its analogs |
| abstract | The racemization method of the optically-rich piperidine-2-carboxanilide compound consists of heating the compound in the presence of alkano or arylalkanoic acid. The method for asymmetric conversion of such compounds consists of heating the compound in the presence of an acid, chiral acid decomposing agent and inert hybrid solvent as described above. |
| priorityDate | 1994-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466242851 |
Total number of triples: 16.